These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11924109)

  • 41. The prevalence of sickle cell anemia in Saudi children and adolescents. A community-based survey.
    Al-Mendalawi MD
    Saudi Med J; 2009 Mar; 30(3):452: author reply 452. PubMed ID: 19271087
    [No Abstract]   [Full Text] [Related]  

  • 42. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.
    Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH
    Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beta-globin gene polymorphism in the Saudi Arab population.
    el-Hazmi MA
    Hum Genet; 1986 May; 73(1):31-4. PubMed ID: 3011645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on sickle cell heterozygotes in Saudi Arabia--interaction with alpha-thalassaemia.
    el-Hazmi MA
    Acta Haematol; 1986; 75(2):100-4. PubMed ID: 3090815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung function and somatic growth in patients with hemoglobin SC sickle cell disease.
    Koumbourlis AC; Lee DJ; Lee A
    Pediatr Pulmonol; 2008 Feb; 43(2):175-8. PubMed ID: 18085696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sickle cell disease: the Lebanese experience.
    Inati A; Jradi O; Tarabay H; Moallem H; Rachkidi Y; El Accaoui R; Isma'eel H; Wehbe R; Mfarrej BG; Dabbous I; Taher A
    Int J Lab Hematol; 2007 Dec; 29(6):399-408. PubMed ID: 17988293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote].
    Diop S; Sene A; Cisse M; Toure AO; Sow O; Thiam D; Diakhate L
    Dakar Med; 2005; 50(2):56-60. PubMed ID: 16295757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
    Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
    Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study.
    Masmas TN; Garly ML; Lisse IM; Rodriques A; Petersen PT; Birgens H
    Hemoglobin; 2006; 30(3):355-64. PubMed ID: 16840226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of sickle cell disease in Saudi Arabia.
    Jastaniah W
    Ann Saudi Med; 2011; 31(3):289-93. PubMed ID: 21623060
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Alaoui-Ismaili FZ; Laghmich A; Ghailani-Nourouti N; Barakat A; Bennani-Mechita M
    Hemoglobin; 2020 May; 44(3):190-194. PubMed ID: 32508152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red cell genetic abnormalities and environmental interactions: a study in Tehamat Aseer.
    el-Hazmi MA
    J Trop Med Hyg; 1987 Apr; 90(2):61-7. PubMed ID: 3560299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya.
    Kosiyo P; Otieno W; Gitaka J; Munde EO; Ouma C
    BMC Infect Dis; 2020 Nov; 20(1):887. PubMed ID: 33238928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients.
    Koenig SC; Becirevic E; Hellberg MS; Li MY; So JC; Hankins JS; Ware RE; McMahon L; Steinberg MH; Luo HY; Chui DH
    Am J Hematol; 2009 Sep; 84(9):603-6. PubMed ID: 19650141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal abnormalities in patients with sickle cell disease: a single center report from Saudi Arabia.
    Aleem A
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):194-9. PubMed ID: 18310866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
    Tubman VN; Bennett CM; Luo HY; Chui DH; Heeney MM
    Pediatr Blood Cancer; 2007 Aug; 49(2):207-10. PubMed ID: 17551985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two different forms of homozygous sickle cell disease occur in Saudi Arabia.
    Padmos MA; Roberts GT; Sackey K; Kulozik A; Bail S; Morris JS; Serjeant BE; Serjeant GR
    Br J Haematol; 1991 Sep; 79(1):93-8. PubMed ID: 1716963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Frequency of sickle-cell anemia in the population of "Cuatro Bocas," Parroquia Ricaurte, Mara municipality, Zulia state, Venezuela].
    Torres-Guerra E; Torres-Guerra T; Valbuena G; Arteaga Vizcaíno M; Soto L
    Invest Clin; 1993; 34(2):99-105. PubMed ID: 8123712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-globin gene haplotypes in the Saudi sickle cell anaemia patients.
    el-Hazmi MA
    Hum Hered; 1990; 40(3):177-86. PubMed ID: 1973147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
    Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
    Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.